Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...

Bain Capital said it will buy Mitsubishi Chemical’s pharma business for $3.37 billion. Sanofi and CD&R signed an Opella share purchase agreement. Biogen partnered with Stoke Therapeutics on a drug for ...

Japan's Seven & I, the parent company of the Japanese 7-Eleven convenience store chain, says it is selling its supermarket ...

Seven & I Holdings plans to select U.S. investment fund Bain Capital as the preferred bidder for a stake in an intermediate company that runs the retail group's supermarket and other operations ...

Bain Capital’s reported move is interestingly timed for several reasons. First, Chemring has an AGM trading update on Wednesday. Second, the stock had been strong of late on the realisation that ...